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THE effects  of  various  lipoxygenase  metabolites  of
arachidonic  acid  (AA)  were  investigated  on  the
growth  of  freshly  isolated  human  bone  marrow
mononuclear cells and marrow stromal cell cultures.
LTB4,  LXA4,  LXB4,  12-HETE  and  15-HETE  (1 m M)
decreased  [3H]-thymidine incorporation  on  marrow
stromal cell cultures without affecting  cell number.
Only  12-HETE  showed  a  dose–response  effect  on
[3H]-thymidine  incorporation.  While  LTB4 (1 m M)
decreased  thymidine  incorporation  on  marrow
mononuclear  cells,  LTC4,  LXA4,  LXB4,  12-HETE  and
15-HETE  had  no  effect.  The  lipoxygenase  inhibitor
NDGA had no effect on both cell types suggesting no
role of endogenous lipoxygenase metabolites on cell
growth.  These results suggest  no important  role of
lipoxygenase metabolites of AA on the proliferation
of  human  marrow  mononuclear  cells  and  marrow
stromal cell cultures.
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Introduction
Human bone marrow stromal cells regulate haemato-
poiesis by interacting directly with marrow haemato-
poietic progenitors and/or by releasing cytokines.1,2
Lipoxygenase  metabolites  of  arachidonic  acid  (AA)
such  as  leukotriene  B4 (LTB4),  LTC4,  lipoxin  A4
(LXA4),  LXB4,  12-hydroxyeicosatetraenoic  acid
(12-HETE),  and  15-HETE  are  produced  by  human
marrow  mononuclear  cells.3,4 Several  of  these AA
metabolites act on the growth of human myeloid and
erythroid  progenitors  in  semi-solid  culture
medium.5–7At this time no study has reported the role
of AA metabolites on the growth of human marrow
stromal cells. These results could be of interest since
the lipidic compound platelet-activating factor (PAF)
stimulates  [3H]-thymidine  incorporation  in  marrow
stromal cell cultures.8 In this study we have assessed
the  effect  of  LTB4,  LTC4,  LXA4,  LXB4,  12-HETE,
15-HETE, and of the lipoxygenase inhibitor nordihy-
droguaiaretic acid (NDGA) on the growth of human
marrow stromal cell cultures and fresh human mono-
nuclear marrow cells.
Materials and methods
Cell cultures
These experiments were performed according to the
Helsinki recommendations. Bone marrow sternal cells
were harvested from untreated patients referred for
diagnosis. Cells collected by aspiration into hepari-
nized tubes were isolated by separation on a Ficoll
gradient (400 3 g, 20min), and washed twice with
Hanks’s balanced salts solution. Mononuclear marrow
cells  were  used  when  the  cell  morphology  was
normal.
Cultures  of  human  bone  marrow  stromal  cells
(mostly  fibroblast-like  cells)  were  established  from
marrow mononuclear cells seeded in 75cm2 culture
flasks in RPMI 1640 with 20% fetal calf serum (FCS)
(Gibco, Cergy Pontoise, France), penicillin (100U/ml)
and  streptomycin  (100m g/ml)  (culture  medium)  at
37°C in 5% CO2 in air as previously described.9 After
one  week,  non-adherent  cells  were  removed  from
culture  flasks. Adherent  cells  were  grown  to  con-
fluence  for  4–5  weeks  with  weekly  changes  of
medium and were subcultured after trypsin treatment
(0.05%   trypsin  for  5min). The  cells  used  in  these
experiments  were  at  the  first  passage.  In  these
experimental  conditions  more  than  99.8%   of  cells
were  CD2- and  CD22- indicating  the  absence  of T -
and B-cells on the layers and 4%  of cells were CD14+
and  CD33+ indicating  a  monocytic/macrophagic
lineage.10,11
Cell proliferation
Freshly isolated marrow mononuclear cells (1 3 105)
were grown in 100m l of IMDM with 10% FCS. LTB4,
LTC4,  LXA4,  LXB4,  12-HETE,  15-HETE  (Tebu,  Le
Perray-en-Yvelines,  France),  NDGA  (Sigma,  Saint
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(10m l 2% of human serum albumin) were added at
the start of the culture. Trypsinized marrow stromal
cells (1 3 104 per well) were plated for 24 hours in
96-well plates in 100 µl of culture medium. Adherent
cells were washed with HBSS and 200m l of serum-free
medium was added to each well for 2 days. Adherent
cells were reactivated with 100m l of RPMI 1640 with
5% FCS. The various compounds were added imme-
diately  after  reactivation. After  60h  of  growth,  all
cultures (in sixplicate (n = 6) samples) w ere pulsed
for 12 h w ith 1 m Ci/ml [3H]-thymidine (Amersham, Les
Ulis,  France)  and the  cells  were  harvested using  a
Skatron cell harvester. Results (in dpm) were com-
pared by Wilcoxon test.
In a separate set of experiments, human marrow
stromal  cells (in triplicate samples) were harvested
after  trypsin  treatment  (0.05%  trypsin  for  5min  at
37°C)  and  counted  by  using  a  haemocytometer.
Results (in cell number) were compared by Mann–
Whitney U-test.
Results
All these experiments were done with bone marrow
cells from 47 different donors. Previous experiments
showed  that  FCS  increased  in  a  dose-dependent
manner [3H]-thymidine incorporation by stromal cells
with 5%  as suboptimal FCS concentration.2
As reported in Table 1, the addition of LTB4, LXA4,
LXB4, 12-HETE and 15-HETE (1m M) significantly (P <
0.001)  decreased  [3H]-thymidine  incorporation  by
cells  cultured  with  5%  FCS.  LTB4,  LXA4,  LXB4,
12-HETE and 15-HETE inhibited by 19 ± 8% , 24 ± 10% ,
22  ±  6% ,  74  ±  6%   and  37  ±  4%  [3H]-thymidine
incorporation, respectively. Except for 12-HETE, no
dose–response curve was found. LTC4 had no effect
on thymidine incorporation. As reported in Table 2,
despite a significant effect on [3H]-thymidine incor-
poration  no  significant  effect  was  found  on  the
number  of  marrow  stromal  cells  after  3  days  of
growth  with  the  different  AA  metabolites  (1m M).
Finally the lipoxygenase inhibitor NDGA (1m M) had
no  significant  (P >  0.05,  six  independent  experi-
ments) effect on the [3H]-thymidine incorporation of
stromal  cell cultures  (3493  ± 1871dpm vs 2664 ±
1372dpm for NDGA-treated cells and control cells,
respectively).
As reported in Table 3, only LTB4 had a significant
effect on the [3H]-thymidine incorporation of freshly
isolated  human  marrow  mononuclear  cells.  NDGA
(1m M) had no effect (P > 0.05, four experiments) on
their thymidine incorporation (90326 ± 9262dpm vs.
81712 ± 8532dpm for NDGA-treated cells and control
cells, respectively).
Discussion
Studies have reported the positive or negative effects
of lipoxygenase metabolites of AA on cell prolifera-
tion.  Thus,  12-HETE  and  15-HETE  stimulate
[3H]-thymidine  incorporation  in  mammary  tumour
cells,12 and  endothelial  cells,13 but  inhibit  it  in
neuroblastoma  cell  cultures.14 LTB4 and LTC4 stim-
ulate  DNA  synthesis  in  cultured  arterial  smooth
muscle cells,15 while 12-HETE decreases the growth
of aortic smooth muscle cells.16 These latter results
are of interest since bone marrow stromal cells share
numerous  phenotypic  similarities  with  vascular
smooth muscle cells.17
The growth of fresh marrow mononuclear cells is
not  affected  by  lipoxygenase  metabolites  of  AA.
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Table 1. Effects of lipoxygenase AA metabolites on  [3H]-thymidine incorporation  of human  bone marrow stromal cells.
Experiments were made with stromal cell cultures from 30 donors. Results (in dpm) are the mean ± SEM from six independent
experiments in sixplicate (n = 6)
Stimuli Controls 1m M 100nM 10nM 1nM 100pM 10pM
LTB4 2625 ± 522 2142 ± 542** 2788 ± 467 3008 ± 736 2831 ± 673 2632 ± 605 2718 ± 547
LTC4 2950 ± 550 3132 ± 638 3151 ± 506 3167 ± 520 2961 ± 533 2905 ± 430 2526 ± 319
LXA4 2577 ± 350 1776 ± 242** 2785 ± 364 2603 ± 363 2785 ± 417 2785 ± 417 2570 ± 393
LXB4 2508 ± 399 1730 ± 283** 2634 ± 421 2221 ± 327 2541 ± 382 2017 ± 367 2575 ± 479
12-HETE 2413 ± 225 524 ± 44** 1577 ± 183** 1731 ± 180** 1944 ± 208* 1789 ± 196* 2057 ± 243
15-HETE 1859 ± 172 1170 ± 111** 1753 ± 213 1642 ± 190 1699 ± 195 1532 ± 179 2398 ± 280
**P < 0.001, *P < 0.01 (Wilcoxon test) compared with control values.
Table 2. Effects of lipoxygenase metabolites of AA on human
marrow stromal cell number. Cell number was determined
after 3 days of growth with AA metabolites (1m M). Results (in
1  3 103 cells)  are  reported  as  mean  ±  SEM  of  four
independent experiments in triplicate
Cell number (3 103) Statistical significance
Controls 6.6 ± 0.5
LTB4 4.9 ± 0.7 P = 0.38
LXA4 6.3 ± 0.7 P = 0.77
LXB4 5.0 ± 0.5 P = 0.14
12-HETE 5.6 ± 0.7 P = 0.53
15-HETE 5.6 ± 0.6 P = 0.46
Statistical significance was determined by Mann–Whitney U-test as
compared with control values.Although statistically significant, the small decrease of
incorporation of  thymidine  with  LTB4 brings  some
doubts  on  its  physiological  meaning.  Micromolar
concentrations  of  LTB4,  LXA4,  LXB4 and  15-HETE
decrease  [3H]-thymidine  incorporation  in  human
bone marrow stromal cell cultures. However the fact
that no dose–response curve was found and that no
effect  was  documented  on  cell  number  cast  some
doubts on the physiological meaning of the observed
effects on thymidine incorporation. In contrast to the
other AA  metabolites,  12-HETE  inhibits  in  a  dose-
dependent manner thymidine incorporation in mar-
row  stromal  cell  cultures.  However  no  effect  was
found on cell counts. An explanation might be that
[3H]-thymidine incorporation is not only an index of
cell  proliferation  but  may  also  reflect  intracellular
events other than  cell division such  as diffusion of
DNA  precursors.18 Another  explanation  for  these
results might be that only a small percentage of cells
were  proliferating  and  that  cell  counts  were  not
sensitive enough to detect changes.
Taken  together  our  results  suggest  no important
role of exogenous lipoxygenase metabolites of AA in
the growth of human bone marrow stromal cells and
mononuclear marrow cells in vitro. Moreover results
with  NDGA  suggest  that  endogenous  lipoxygenase
metabolites had no role on FCS-induced cell growth.
These results markedly differ from data showing that
PAF  stimulates  [3H]-thymidine  incorporation  in
freshly isolated human mononuclear marrow cells,19
and marrow stromal cell cultures.8
References
1. Mayani  H,  Guilbert  LJ,  Janowska-Wieczorek A.  Biology  of  the  hemo-
poietic microenvironment. Eur J Haematol 1992; 49: 225–233.
2. Rougier F , Dupuis F , Denizot Y. Human bone marrow fibroblasts  – an
overview  of  their  characterization,  proliferation  and  inflammatory
mediator production. Hematol Cell Ther 1996; 38: 241–246.
3. Stenke L, Laur´ en L, Reizenstein P, Lindgren JA. Leukotriene production
by fresh human bone marrow cells: evidence of altered lipoxygenase
activity  in  chronic  myelocytic  leukemia.  Exp  Hematol 1987;  15:
203–207.
4. Stenke L, Mansour M, Edenius C, Reizenstein P, Lindgren JA. Formation
and proliferative effects of lipoxins in human bone marrow. Biochem
Biophys Res Commun 1991; 180: 255–261.
5. Claesson HE, Dahlberg N, Gahrton G. Stimulation of human myelopoiesis
by  leukotriene  B4.  Biochem  Biophys  Res  Commun 1985;  131:
579–585.
6. Miller AM, Weiner RS, Ziboh VA. Evidence for the role of leukotrienes C4
and  D4  as  essential  intermediates  in  CSF-stimulated  human  myeloid
colony formation. Exp Hematol 1986; 14: 760–765.
7. Snyder DS, Desforges JF . Lipoxygenase metabolites of arachidonic acid
modulate hematopoiesis. Blood 1986; 67: 1675–1679.
8. Rougier F , Dupuis F , Cornu E, Dulery C, Praloran V , Denizot Y. Platelet-
activating factor and antagonists modulate DNA synthesis in human bone
marrow stromal cell cultures. J Lipid Mediators Cell Signalling 1997; 16:
147–153.
9. Denizot Y, Rougier F , Dupuis F , Verger C, Dulery C, Laskar M, Aldigier JC,
Praloran V . PAF and haematopoiesis. VIII. Biosynthesis and metabolism of
platelet-activating  factor  by  human  bone  marrow  stromal  cells.  Exp
Hematol 1996; 24: 1327–1332.
10. Rougier F , Cornu E, Gachard N, Praloran V , Denizot Y. Tumor necrosis
factor-alpha  (TNF-a )  stimulates  the  growth  of  human  bone  marrow
stromal cells. Med Inflamm 1997; 6: 233–235.
11. Fixe P, Rougier F , Ostyn E, Gachard N, Faucher JL, Praloran V , Denizot Y.
Spontaneous and inducible production of macrophage colony-stimulat-
ing factor by human bone marrow stromal cells. Eur Cytokine Netw
1997; 8: 91–95.
12. Lee PPH, Ip MM. Regulation of proliferation of rat mammary tumor cells
by  inhibitors of cyclooxygenase and lipoxygenase.  Prostagland  Leuk
Essent Fatty 1992; 45: 21–31.
13. Setty  BNY,  Graeber  JE,  Stuart  MJ. The  mitogenic  effect  of  15-  and
12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated
via  diacylglycerol  kinase  inhibition.  J  Biol  Chem 1987;  262:
17613–17622.
14. Werner EJ, Walenga RW , Dubowy RL, Boone S, Stuart MJ. Inhibition of
human  malignant  neuroblastoma  cell  DNA synthesis by lipoxygenase
metabolites of arachidonic acid. Cancer Res 1985; 45: 561–563.
15. Palmberg L, Lindgren JA, Thyberg J, Claesson HE. On the mechanism of
induction of DNA synthesis in cultured arterial smooth muscle cells by
leukotrienes.  Possible  role  of  prostaglandin  endoperoxide  synthase
products  and  platelet-derived  growth  factor.  J  Cell  Sci 1991;  98:
141–149.
16. Smith DL, Willis AL, Mahmud I. Eicosanoid effects on cell proliferation in
vitro:  relevance to  atherosclerosis.  Prostaglandins  Leukotrienes  Med
1984; 16: 1–10.
17. Galmiche MC, Koteliansky VE, Bri` ere J, Herv´ e P, Charbord P . Stromal cells
from  human  long-term  marrow  cultures  are  mesenchymal  cells  that
differentiate following a vascular smooth muscle differentiation pathway.
Blood 1993; 82: 66–76.
18. Bazill  GW ,  Dexter TM.  Platelet-activating  factor  antagonist  L-652,731
inhibits thymidine transport. Biochem Pharmacol 1989; 38: 373–374.
19. Denizot Y, Dupuis F , Trimoreau F , Verger C, Allegraud A, Praloran V . PAF
and haematopoiesis: IX. Platelet-activating factor increases DNA synthe-
sis in human bone marrow cells. J Lipid Mediators Cell Signalling 1996;
15: 1–4.
ACKNOWLEDGMENTS. The  authors  are  grateful  to  the ‘Ligue  Nationale
Contre le Cancer’ (Comit´ e de la Corr` eze et de la Creuse) and the ‘Conseil
R´ egional du Limousin’ for funding our project. F . Dupuis is the recipient of a
grant from the Association pour la Recherche sur le Cancer (ARC). This paper
is the first of a series: Arachidonic acid metabolites and haematopoiesis.
Received 27 October 1997;
accepted 31 October 1997
Effects of lipoxygenase metabolites of arachidonic acid
Mediators of Inflammation · Vol 7 · 1998 33
Table 3. Effects of lipoxygenase AA metabolites on [3H]-thymidine incorporation of freshly isolated human mononuclear bone
marrow cells. Experiments were made with marrow cells from 14 donors. Results (in dpm) are the mean ± SEM from four
independent experiments in sixplicate (n = 6)
Stimuli Controls 1m M 100nM 10nM 1nM 100pM
LTB4 58499 ± 9276 46780 ± 11243* 61661 ± 13177 66545 ± 11617 66075 ± 11169 63568 ± 10476
LTC4 69415 ± 6558 64311 ± 7881 74968 ± 8451 70270 ± 7475 73999 ± 10340 71075 ± 8278
LXA4 57227 ± 12448 54848 ± 13025 54362 ± 11939 64290 ± 15259 58318 ± 13514 51295 ± 11268
LXB4 100218 ± 13485 95781 ± 12384 94208 ± 12468 87635 ± 11725 83321 ± 11639 80401 ± 12070
12-HETE 73871 ± 10048 69283 ± 10318 73732 ± 8534 73157 ± 10490 73050 ± 9269 76918 ± 10998
15-HETE 77168 ± 9008 73956 ± 8742 75191 ± 8449 80799 ± 10372 81043 ± 8788 77516 ± 8635
*P < 0.01 Wilcoxon test.